Prediction of a Null Response to Pegylated Interferon α-2b Plus Ribavirin in Patients with High Viral Load Genotype 1b Hepatitis C

Yuki Wada,Hideyuki Tamai,Akira Kawashima,Naoki Shingaki,Yoshiyuki Mori,Masanori Kawaguchi,Kosaku Moribata,Hisanobu Deguchi,Kazuki Ueda,Izumi Inoue,Takao Maekita,Mikitaka Iguchi,Jun Kato,Masao Ichinose

Prediction of a Null Response to Pegylated Interferon α-2b Plus Ribavirin in Patients with High Viral Load Genotype 1b Hepatitis C

2014

Yuki Wada
Hideyuki Tamai
Akira Kawashima
Naoki Shingaki
Yoshiyuki Mori
Masanori Kawaguchi
Kosaku Moribata
Hisanobu Deguchi
Kazuki Ueda
Izumi Inoue
Takao Maekita
Mikitaka Iguchi
Jun Kato
Masao Ichinose

Background/Aims The present study aimed to clarify whether virological response within 2 weeks after therapy initiation can predict a null response to pegylated interferon α-2b plus ribavirin therapy in patients with high viral load genotype 1b hepatitis C.

Keywords:

Hepatitis C
Hepatitis C virus
Cancer research
Genotype
Pegylated interferon
Virology
Peginterferon alfa-2b
General surgery
Ribavirin
Medicine
Viral load
Area under the curve
Immunology
Hepatitis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations